Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria

被引:87
作者
Klouwenberg, Peter M. C. Klein [1 ,2 ]
Ong, David S. Y. [1 ,2 ]
Bonten, Marc J. M. [2 ,3 ]
Cremer, Olaf L. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Intens Care, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands
关键词
Systemic inflammatory response syndrome; Sepsis; Intensive care unit; Clinical trial; Epidemiology; Diagnosis; INFLAMMATORY RESPONSE SYNDROME; ORGAN DYSFUNCTION; ILL PATIENTS; MULTICENTER; EPIDEMIOLOGY; SCORE; GUIDELINES; MORTALITY; EFFICACY; FAILURE;
D O I
10.1007/s00134-012-2549-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
To quantify the effects of minor variations in the definition and measurement of systemic inflammatory response syndrome (SIRS) criteria and organ failure on the observed incidences of sepsis, severe sepsis and septic shock. We conducted a prospective, observational study in a tertiary intensive care unit in The Netherlands between January 2009 and October 2010. A total of 1,072 consecutive adults were included. We determined the upper and lower limits of the measured incidence of sepsis by evaluating the influence of the use of an automated versus a manual method of data collection, and variations in the number of SIRS criteria, concurrency of SIRS criteria, and duration of abnormal values required to make a particular diagnosis. The measured incidence of SIRS varied from 49 % (most restrictive setting) to 99 % (most liberal setting). Subsequently, the incidences of sepsis, severe sepsis and septic shock ranged from 22 to 31 %, from 6 to 27 % and from 4 to 9 % for the most restrictive versus the most liberal measurement settings, respectively. In non-infected patients, 39-98 % of patients had SIRS, whereas still 17-6 % of patients without SIRS had an infection. The apparent incidence of sepsis heavily depends on minor variations in the definition of SIRS and mode of data recording. As a consequence, the current consensus criteria do not ensure uniform recruitment of patients into sepsis trials.
引用
收藏
页码:811 / 819
页数:9
相关论文
共 36 条
[1]   Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].
Abraham, E ;
Reinhart, K ;
Opal, S ;
Demeyer, I ;
Doig, C ;
Rodriguez, AL ;
Beale, R ;
Svoboda, P ;
Laterre, PF ;
Simon, S ;
Light, B ;
Spapen, H ;
Stone, J ;
Seibert, A ;
Peckelsen, C ;
De Deyne, C ;
Postier, R ;
Pettilä, V ;
Sprung, CL ;
Artigas, A ;
Percell, SR ;
Shu, V ;
Zwingelstein, C ;
Tobias, J ;
Poole, L ;
Stolzenbach, JC ;
Creasey, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247
[2]   Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study [J].
Alberti, C ;
Brun-Buisson, C ;
Burchardi, H ;
Martin, C ;
Goodman, S ;
Artigas, A ;
Sicignano, A ;
Palazzo, M ;
Moreno, R ;
Boulmé, R ;
Lepage, E ;
Le Gall, JR .
INTENSIVE CARE MEDICINE, 2002, 28 (02) :108-121
[3]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[4]   Septic shock [J].
Annane, D ;
Bellissant, E ;
Cavaillon, JM .
LANCET, 2005, 365 (9453) :63-78
[5]   Corticosteroid Treatment and Intensive Insulin Therapy for Septic Shock in Adults A Randomized Controlled Trial [J].
Annane, Djillali ;
Cariou, Alain ;
Maxime, Virginie ;
Azoulay, Elie ;
D'honneur, Gilles ;
Timsit, Jean Francois ;
Cohen, Yves ;
Wolf, Michel ;
Fartoukh, Muriel ;
Adrie, Christophe ;
Santre, Charles ;
Bollaert, Pierre Edouard ;
Mathonet, Armelle ;
Amathieu, Roland ;
Tabah, Alexis ;
Clec'h, Christophe ;
Mayaud, Julien ;
Lejeune, Julie ;
Chevret, Sylvie .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (04) :341-348
[6]   Quality of data collected for severity of illness scores in the Dutch National Intensive Care Evaluation (NICE) registry [J].
Arts, D ;
de Keizer, N ;
Scheffer, GJ ;
de Jonge, E .
INTENSIVE CARE MEDICINE, 2002, 28 (05) :656-659
[7]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[8]   Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study [J].
Blanco, Jesus ;
Muriel-Bombin, Arturo ;
Sagredo, Victor ;
Taboada, Francisco ;
Gandia, Francisco ;
Tamayo, Luis ;
Collado, Javier ;
Garcia-Labattut, Angel ;
Carriedo, Demetrio ;
Valledor, Manuel ;
De Frutos, Martin ;
Lopez, Maria-Jesus ;
Caballero, Ana ;
Guerra, Jose ;
Alvarez, Braulio ;
Mayo, Agustin ;
Villar, Jesus .
CRITICAL CARE, 2008, 12 (06)
[9]   A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis [J].
Bloos, Frank ;
Hinder, Frank ;
Becker, Karsten ;
Sachse, Svea ;
Dessap, Armand Mekontso ;
Straube, Eberhard ;
Cattoir, Vincent ;
Brun-Buisson, Christian ;
Reinhart, Konrad ;
Peters, Georg ;
Bauer, Michael .
INTENSIVE CARE MEDICINE, 2010, 36 (02) :241-247
[10]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655